Some healthcare providers have partnered with AI gun detection company ZeroEyes. The company adds its software to hospitals’ existing security camera systems to identify a gun before the shooter strikes. The post How One AI Company Is Tackling Gun Violence at Hospitals appeared first on MedCity News.
Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio in 2021. 2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. The post Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal appeared first on MedCity News.
As healthcare leaders look for the low-hanging fruit for AI and automation investments in the revenue cycle, there are three things that should be considered to achieve maximum impact on labor effectiveness. The post Revenue Cycle Automation: 3 Considerations For Optimal ROI appeared first on MedCity News.
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Women’s Health? appeared first on MedCity News.
Beam Therapeutics’ first clinical data in the rare disease alpha-1 antitrypsin deficiency “set a bar for efficacy in the space,” according to one analyst. But the ongoing market slide poses challenges for biotech companies aiming to raise money by selling stock. The post Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M…
Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen, however, if Walgreens will perform better under Sycamore Partners. The post Walgreens to Be Acquired by Sycamore Partners: Where Did the Retail Giant Go Wrong?…
Houston Methodist Coordinate Care is reducing costs through a partnership with Koda Health, a digital platform that guides patients through their end-of-life choices. Preliminary findings show the technology resulted in a 19% reduction in the total cost of care for patients at the end of their life, which equals nearly $9,000 in savings per patient….
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes. But the topline results don’t show an advantage over Eli Lilly’s commercialized obesity medication, Zepbound. The post Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss…
[Sponsored] Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers. The post Everything You Need to Know About Sterilization Cases and Their Role in Healthcare appeared first on MedCity News.
When home dialysis is done right, care partners quickly discover they are becoming an integral part of the process as engaged, informed participants rather than uninformed outside observers. By knowing more, care partners can worry a lot less. The post When Dialysis Comes Home, Patients and Care Partners Flourish appeared first on MedCity News.